News

Unlocking the Potential of Ent-Idoxuridine Clinical Applications

Ent-Idoxuridine, also known as 5-iodo-2'-deoxyuridine, is a cytosolic DNA synthesis inhibitor that acts by blocking the conversion of deoxycytidine to deoxyadenosine through the inhibition of the enzyme deoxycytidine kinase. As an enantiomer of idoxuridine, it shares the same mechanism of action. Notably, ent-idoxuridine is resistant to exonucleases and has demonstrated effectiveness in treating immunodeficiency caused by HIV.CAS Number and Chemical Properties:English Name: IdoxuridineEnglish Synonyms:  2'-Deoxy-L-5-iodouridine CAS Number: 162239-35-2Molecular Formula: C9H11IN2O [...]

Jul 24, 2025 Product News 687 Views Read More

Enabling Advanced Biodegradation & Environmental Microbiology Research

At Finetech, we are proud to offer high-purity β-Ketoadipate (CAS: 689-31-6), a critical intermediate in the β-ketoadipate pathway—a major route in the microbial degradation of aromatic compounds. As an essential molecule in biodegradation, metabolic engineering, and environmental microbiology, β-Ketoadipate continues to support groundbreaking research across multiple disciplines. 🔬 Product Applications: Microbial degradation pathways of aromatic pollutants Metabolic engineering for biotransformation and synthetic biology Bioremediation research involving [...]

Jul 24, 2025 Product News 2675 Views Read More

Idarubicin: Mechanism of Action, Side Effects, and Clinical Applications in Cancer Treatment

Idarubicin 57852-57-0is a potent chemotherapy drug belonging to the anthracycline class, primarily used in the treatment of various types of cancer, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). Its mechanism of action, side effects, and clinical applications make it a crucial component of cancer treatment regimens.Mechanism of Action:Idarubicin exerts its anticancer effects by interfering with the DNA and RNA synthesis of cancer cells. It does so by intercalating between DNA base pairs, inhibiting the activity of topoisomerase II enzyme, and generating free radi [...]

Jul 24, 2025 Product News 853 Views Read More